This activity is no longer available for credit, however its content is still relevant for your educational needs.

Target Audience
This activity was developed for pharmacy directors, P&T Committee members, managed care pharmacists, oncology pharmacists, and other key stakeholders who wish to enhance their knowledge concerning the implementation of a value-based benefit design for cancer care.

Learning Objectives
At the completion of this activity participants should be able to:

• Incorporate health economics studies into the treatment of multiple myeloma
• Recognize the role of value (cost, quality, and access) of current therapy considerations in the treatment of multiple myeloma
• Identify the intersection of epidemiologic shifts in the patient with multiple myeloma, total therapy cost considerations, and new diagnostic measures, on achieving value-based clinical treatment
• Understand how the NCCN clinical practice treatment guidelines are aiding all stakeholders in attaining value-based cancer care amidst rising new product costs

Disclosure Statement
Before the activity, all faculty will disclose the existence of any financial interest and/or relationship(s) they might have with the manufacturer(s) of any commercial products(s) to be discussed during their presentation(s): honoraria, expenses, grants, consulting roles, speakers’ bureau membership, stock ownership, or other special relationships. Presenters will inform participants of any off-label discussions.

The associates of Medical Learning Institute, Inc. have no financial relationships to disclose. The associates of Center of Excellence Media, LLC, have no financial relationships to disclose.

Faculty Disclosures
Robyn Graham, PharmD has nothing to disclose.


*Content will include non-FDA-approved uses.

Disclaimer
The information provided in this CE activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient's medical condition.